ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Acurx Successfully Completes Ph1 Clinical Trial for ACX-362E in CDI americanpharmaceuticalreview
September 03, 2019Acurx Pharmaceuticals announced its lead product candidate, ACX-362E, has successfully completed the 68-subject, double-blind, placebo-controlled, multiple-ascending dose Phase 1 clinical trial of ACX-362E in healthy volunteers.
Pharma Sources Insight January 2025
